Page last updated: 2024-10-26

donepezil and Charles Bonnet Syndrome

donepezil has been researched along with Charles Bonnet Syndrome in 1 studies

Donepezil: An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.
donepezil : A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one : A member of the class of indanones that is 5,6-dimethoxyindan-1-one which is substituted at position 2 by an (N-benzylpiperidin-4-yl)methyl group.

Charles Bonnet Syndrome: Repetitive visual hallucinations experienced mostly by elderly with diminished visual acuity or visual field loss, with awareness of the fictional nature of their hallucinations. It is not associated with delusions and other sensory hallucinations.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Singh, A1
Karasin, J1
Madhusoodanan, S1

Other Studies

1 other study available for donepezil and Charles Bonnet Syndrome

ArticleYear
The sound of music: A rare case of auditory Charles Bonnet syndrome in an elderly male.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2019, Volume: 31, Issue:2

    Topics: Aged; Brief Psychiatric Rating Scale; Charles Bonnet Syndrome; Cholinesterase Inhibitors; Cochlear I

2019